Bionano Announces 2023 Winners of its Innovator Research Grant Program

• Grand prize winner, Dr. Michael Khodadoust at Stanford University in Palo Alto, California, will use the Saphyr system for research into CTCL (cutaneous t-cell lymphoma)
  
• Runner up prize winners are Dr. Afia Hasnain at The Hospital for Sick Children in Toronto, Canada, who will investigate ALL (acute lymphoblastic leukemia) samples using Children’s Oncology Group protocols, and Dr. Stefan Rentas at Duke University in Raleigh-Durham, North Carolina, who will study brain tumors and lymphomas
• An additional 12 prize winners across Europe, the United States, South America and Southeast Asia were awarded complimentary laboratory services
• 190+ grant submissions were received from 46 countries
• Submissions focused on a variety of applications including genetic disease, cancer, reproductive health, cell and gene therapy, and plant and animal research
  

SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the 2023 winners of its Innovator Research Grant program, including grand prize winner Dr. Michael Khodadoust at Stanford University. Runner up prize winners are The Hospital for Sick Children, whose project will be led by Dr. Afia Hasnain and Duke University, whose project will be led by Dr. Stefan Rentas. All three winners will receive use of a Saphyr system for a period of time and optical genome mapping (OGM) reagents to conduct their project. Additionally, 12 other winners from around the world have been awarded complimentary OGM services from Bionano Laboratories.

Bionano’s Innovator Research program was established to fuel novel research using the company’s OGM products to detect relevant structural variants (SVs), demonstrating OGM’s potential to advance discoveries and innovation in ways that may elevate health and wellness for all people. There were over 190 grant applications submitted from 46 countries covering research topics including cancer (72 applications encompassing hematological malignancies, multiple cancer types and solid tumors), genetic disease (64), reproductive health (16), complex diseases (13), cell and gene therapy (7), plant and animal research (3), infectious diseases (1) and other areas (15).